Clinical Trial: Safflower (Carthamus Tinctorius L.) Granules for Sepsis-associated Coagulopathy

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07897006) titled 'Safflower (Carthamus Tinctorius L.) Granules for Sepsis-associated Coagulopathy' on Oct. 12.

Brief Summary: Sepsis is a life-threatening condition in which infection triggers widespread inflammation and blood clotting abnormalities. Many patients with sepsis develop coagulopathy (impaired blood clotting), which contributes to organ damage and death. Safflower (Carthamus tinctorius L.) is a traditional Chinese medicine herb with documented anticoagulant, anti-platelet, and blood vessel-protective properties. This randomized, double-blind, placebo-controlled trial will enroll 210 adult patients with sepsis-associated coagulopathy at R...